Venture Capital

A Wisconsin-based company focused on stem cell cytogenetics and characterization has secured special state loan and earns highly sought after certification in state’s angel investor tax credit program Cell Line Genetics, LLC, has secured a $250,000 loan through Wisconsin’s Technology Venture Fund program. Additionally,...

The number of filers for first-time unemployment claims fell last week, though they remain at very high levels. Tom Koulopoulos, author of "The Innovation Zone," tells Kelsey Hubbard historical periods of high unemployment proceed periods of extremely high innovation....

Commercial credit crunch: Private equity capital still available
In the current economic downturn, banks are not lending as much money to businesses to help meet their capital needs. And, the money banks lend tends to be weighed down by higher borrowing costs. For CEOs who...

MADISON - Mithridion, Inc., a drug development company focusing on serious Central Nervous System disorders, including Alzheimer's disease (AD), announced today that it has been selected to make podium presentations at two major biotechnology venture investment conferences. The 2nd Annual BIO National Venture Conference...

The mounting annual trillion-dollar risk to businesses from corporate information loss and consumer data leakage gains perspective through the comparable magnitude of the federal stimulus package. The costs, liabilities and risks of lost, stolen, inappropriately accessed and improperly disposed information are astronomical and growing. ...

Promega Corporation, a provider of DNA and RNA Analysis, will plant a tree for each GoTaq Hot Start product purchased through May 31st. This green initiative is designed to compliment the mission of life scientists around the world - to improve the lives of others...

On March 2, 2009, the U.S. Supreme Court granted a writ of certiorari in Reed Elsevier, Inc. v. Muchnik This case presents a potentially crucial issue for copyright owners seeking to enforce their rights in court: Must a copyright owner obtain a copyright registration before...

Cellectar, a privately held radiopharmaceuticals company that designs and develops products to detect, treat and monitor human cancers, today announced that the U.S. Food and Drug Administration (FDA) has cleared the Company's Investigational New Drug (IND) application for its 131I-CLR1404 drug candidate for testing in...